CS logo
small CS logo
Ematologia - Ospedale San Carlo

Potenza, Italy

About Ematologia - Ospedale San Carlo


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Ematologia - Ospedale San Carlo


During the past decade, Ematologia - Ospedale San Carlo conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Ematologia - Ospedale San Carlo" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Janssen-Cilag S.p.A." with 1 trials as a collaborator and "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Ematologia - Ospedale San Carlo


According to Clinical.Site data, the most researched conditions in "Ematologia - Ospedale San Carlo" are "Acute Myeloid Leukemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials), "Follicular Lymphoma" (2 trials) and "ALL Ph Positive" (1 trials). Many other conditions were trialed in "Ematologia - Ospedale San Carlo" in a lesser frequency.

Clinical Trials Intervention Types at Ematologia - Ospedale San Carlo


Most popular intervention types in "Ematologia - Ospedale San Carlo" are "Drug" (12 trials), "Other" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ibrutinib" (2 trials), "Observation" (2 trials), "Allogeneic SCT or Autologous SCT" (1 trials), "Bendamustine + Rituximab" (1 trials) and "Bleomycin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Ematologia - Ospedale San Carlo


The vast majority of trials in "Ematologia - Ospedale San Carlo" are 19 trials for "All" genders.

Clinical Trials Status at Ematologia - Ospedale San Carlo


Currently, there are NaN active trials in "Ematologia - Ospedale San Carlo". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ematologia - Ospedale San Carlo, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ematologia - Ospedale San Carlo, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".